Effects of Astragalus injection and Salvia Miltiorrhiza injection on serum inflammatory markers in patients with stable coronary heart disease: a randomized controlled trial protocol

BACKGROUND: Coronary heart disease (CHD) is a clinical syndrome caused by coronary atherosclerosis (AS) or functional changes in coronary arteries. We have previously reported that astragaloside IV (in astragalus) and tanshinone IIA (in Salvia miltiorrhiza) improve myocardial ischemic injury. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zhihao, Liu, Yuntao, Zhao, Zhen, Yan, Xia, Wang, Dawei, Liu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076985/
https://www.ncbi.nlm.nih.gov/pubmed/32178701
http://dx.doi.org/10.1186/s13063-020-4109-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076985/
https://www.ncbi.nlm.nih.gov/pubmed/32178701
http://dx.doi.org/10.1186/s13063-020-4109-6

Ejemplares similares